Free Trial

GSA Capital Partners LLP Buys Shares of 6,578 Plexus Corp. (NASDAQ:PLXS)

Plexus logo with Computer and Technology background

GSA Capital Partners LLP acquired a new stake in Plexus Corp. (NASDAQ:PLXS - Free Report) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 6,578 shares of the technology company's stock, valued at approximately $899,000.

Other hedge funds have also recently bought and sold shares of the company. Quest Partners LLC raised its position in Plexus by 36,700.0% in the 2nd quarter. Quest Partners LLC now owns 368 shares of the technology company's stock valued at $38,000 after purchasing an additional 367 shares in the last quarter. Innealta Capital LLC acquired a new position in Plexus during the 2nd quarter worth approximately $51,000. Farther Finance Advisors LLC grew its holdings in Plexus by 89.4% during the 3rd quarter. Farther Finance Advisors LLC now owns 464 shares of the technology company's stock worth $63,000 after acquiring an additional 219 shares in the last quarter. EntryPoint Capital LLC increased its position in shares of Plexus by 56.2% in the 1st quarter. EntryPoint Capital LLC now owns 976 shares of the technology company's stock valued at $93,000 after purchasing an additional 351 shares during the last quarter. Finally, GAMMA Investing LLC raised its holdings in shares of Plexus by 190.1% in the 3rd quarter. GAMMA Investing LLC now owns 760 shares of the technology company's stock valued at $104,000 after purchasing an additional 498 shares in the last quarter. Institutional investors and hedge funds own 94.45% of the company's stock.

Plexus Stock Performance

Shares of NASDAQ PLXS traded down $0.58 during trading hours on Friday, reaching $153.13. The stock had a trading volume of 133,595 shares, compared to its average volume of 181,325. The firm has a market cap of $4.17 billion, a price-to-earnings ratio of 38.19 and a beta of 0.87. Plexus Corp. has a fifty-two week low of $90.18 and a fifty-two week high of $169.41. The firm has a 50-day moving average of $139.43 and a 200-day moving average of $122.43. The company has a current ratio of 1.51, a quick ratio of 0.71 and a debt-to-equity ratio of 0.07.

Plexus (NASDAQ:PLXS - Get Free Report) last announced its earnings results on Wednesday, October 23rd. The technology company reported $1.85 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.55 by $0.30. Plexus had a net margin of 2.82% and a return on equity of 9.51%. The business had revenue of $1.05 billion for the quarter, compared to analyst estimates of $1.01 billion. During the same period last year, the firm posted $1.44 earnings per share. The company's revenue for the quarter was up 2.6% compared to the same quarter last year. Equities research analysts predict that Plexus Corp. will post 6.13 earnings per share for the current year.

Insider Activity

In related news, CEO Todd P. Kelsey sold 2,000 shares of Plexus stock in a transaction on Monday, August 19th. The shares were sold at an average price of $125.00, for a total value of $250,000.00. Following the transaction, the chief executive officer now directly owns 85,026 shares in the company, valued at $10,628,250. This trade represents a 2.30 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Michael J. Running sold 579 shares of the company's stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $153.93, for a total transaction of $89,125.47. Following the transaction, the insider now owns 1,569 shares of the company's stock, valued at approximately $241,516.17. The trade was a 26.96 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 35,552 shares of company stock valued at $5,500,872. Insiders own 2.39% of the company's stock.

Analysts Set New Price Targets

Several equities analysts recently commented on the company. KeyCorp began coverage on Plexus in a report on Tuesday, October 22nd. They issued a "sector weight" rating on the stock. Needham & Company LLC raised their target price on Plexus from $144.00 to $162.00 and gave the stock a "buy" rating in a research report on Friday, October 25th. Benchmark upped their price target on Plexus from $150.00 to $165.00 and gave the company a "buy" rating in a report on Monday, October 28th. Finally, StockNews.com lowered shares of Plexus from a "buy" rating to a "hold" rating in a research note on Wednesday, November 6th. Four investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Hold" and an average target price of $133.50.

Read Our Latest Analysis on PLXS

Plexus Company Profile

(Free Report)

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.

Further Reading

Institutional Ownership by Quarter for Plexus (NASDAQ:PLXS)

Should you invest $1,000 in Plexus right now?

Before you consider Plexus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Plexus wasn't on the list.

While Plexus currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Can Blackwell Propel the Stock to $200+ in 2025?
These Top Stocks in 2024 Will Continue to be Big Winners in 2025
’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines